Subtopic Deep Dive
von Willebrand Disease Molecular Genetics
Research Guide
What is von Willebrand Disease Molecular Genetics?
Von Willebrand Disease Molecular Genetics studies mutations in the VWF gene that cause quantitative or qualitative defects in von Willebrand factor, leading to the most common inherited bleeding disorder.
VWD classification relies on VWF gene sequencing and multimer analysis to distinguish type 1 (partial quantitative deficiency), type 2 (qualitative defects), and type 3 (virtually complete deficiency). Studies like MCMDM-1VWD and Canadian cohort analyses identified over 100 mutations correlating genotypes with bleeding phenotypes (Goodeve et al., 2006; 397 citations; James et al., 2006; 346 citations). Sadler provided foundational biochemistry and genetics review (Sadler, 1998; 1355 citations).
Why It Matters
Genetic profiling of VWD enables precision diagnosis, distinguishing type 1 from type 2 variants via multimer patterns, as shown in Ruggeri and Zimmerman's analysis of variant VWD using SDS-agarose electrophoresis (1980; 508 citations). This informs desmopressin (DDAVP) responsiveness in pediatric cases, reducing plasma-derived product exposure (Revel-Vilk et al., 2013; 3514 citations). Insights drive recombinant VWF therapy development and ABO blood group influence assessment on VWF levels (Sadler et al., 2006; 1126 citations; James et al., 2021; 485 citations).
Key Research Challenges
Genotype-Phenotype Correlation
Linking specific VWF mutations to bleeding severity remains inconsistent across type 1 VWD families due to variable penetrance. MCMDM-1VWD study found partial penetrance in 72 pedigrees (Goodeve et al., 2006; 397 citations). Canadian cohort sequencing revealed diverse mutations but incomplete phenotype matches (James et al., 2006; 346 citations).
Type 2 Variant Classification
Distinguishing type 2A, 2B, 2M, and 2N subtypes requires multimer analysis and functional assays. Ruggeri and Zimmerman identified aberrant multimers in variant VWD via electrophoresis (1980; 508 citations). Updated Subcommittee report refined pathophysiology but noted assay standardization gaps (Sadler et al., 2006; 1126 citations).
Mutation Detection Sensitivity
Sequencing misses deep intronic or large deletions in VWF gene. European and Canadian studies detected novel mutations but emphasized need for comprehensive screening (Tosetto et al., 2006; 523 citations; James et al., 2006; 346 citations).
Essential Papers
Hematological Problems in Pediatric Intensive Care
Shoshana Revel‐Vilk, Peter N. Cox, Nancy Robitaille et al. · 2013 · Pediatric and adolescent medicine · 3.5K citations
Desmopressin (1-deamino-8-D-arginine vasopressin, DDAVP) has been used in children with von Willebrand disease (VWD) and Hemophilia A for almost 35 years. This treatment has substantially lowered t...
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
J. Evan Sadler · 1998 · Annual Review of Biochemistry · 1.4K citations
Von Willebrand factor (VWF) is a blood glycoprotein that is required for normal hemostasis, and deficiency of VWF, or von Willebrand disease (VWD), is the most common inherited bleeding disorder. V...
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
J. Evan Sadler, Ulrich Budde, Jeroen Eikenboom et al. · 2006 · Journal of Thrombosis and Haemostasis · 1.1K citations
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)
Alberto Tosetto, Francesco Rodeghiero, Giancarlo Castaman et al. · 2006 · Journal of Thrombosis and Haemostasis · 523 citations
Variant von Willebrand's Disease
Zaverio M. Ruggeri, T S Zimmerman · 1980 · Journal of Clinical Investigation · 508 citations
We have examined the multimeric composition of factor VIII/von Willebrand factor in plasma and platelet lysates by means of sodium dodecyl sulfate agarose electrophoresis followed by staining with ...
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease
Paula James, Nathan T. Connell, Barbara Ameer et al. · 2021 · Blood Advances · 485 citations
Background: von Willebrand disease (VWD) is the most common inherited bleeding disorder known in humans. Accurate and timely diagnosis presents numerous challenges. Objective: These evidence-based ...
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)
Anne Goodeve, Jeroen Eikenboom, Giancarlo Castaman et al. · 2006 · Blood · 397 citations
Abstract Type 1 von Willebrand disease (VWD) is characterized by a personal and family history of bleeding coincident with reduced levels of normal plasma von Willebrand factor (VWF). The molecular...
Reading Guide
Foundational Papers
Start with Sadler (1998; 1355 citations) for VWF biochemistry and genetics basics; then Ruggeri and Zimmerman (1980; 508 citations) for multimer analysis in variant VWD; follow with Sadler et al. (2006; 1126 citations) for classification updates.
Recent Advances
James et al. (2021; 485 citations) for ASH/ISTH/NHF/WFH diagnostic guidelines; Revel-Vilk et al. (2013; 3514 citations) for pediatric treatment genetics.
Core Methods
VWF gene sequencing (all exons), SDS-agarose gel electrophoresis for multimers (Ruggeri 1980), quantitative bleeding scores (Tosetto et al., 2006), and cohort pedigree analysis (Goodeve et al., 2006).
How PapersFlow Helps You Research von Willebrand Disease Molecular Genetics
Discover & Search
Research Agent uses citationGraph on Sadler (1998; 1355 citations) to map VWF genetics literature, revealing connections to Goodeve et al. (2006) and James et al. (2006). exaSearch queries 'VWF gene mutations type 1 VWD penetrance' for 250M+ OpenAlex papers, while findSimilarPapers expands from Revel-Vilk et al. (2013; 3514 citations) to pediatric applications.
Analyze & Verify
Analysis Agent applies readPaperContent to extract mutation tables from James et al. (2006), then runPythonAnalysis with pandas to quantify allele frequencies across cohorts. verifyResponse (CoVe) cross-checks claims against Sadler et al. (2006) guidelines, with GRADE grading for evidence strength in phenotype correlations.
Synthesize & Write
Synthesis Agent detects gaps in type 2 genotype-phenotype data via contradiction flagging across Tosetto et al. (2006) and Ruggeri (1980). Writing Agent uses latexEditText for mutation diagrams, latexSyncCitations to integrate 10+ VWD papers, and latexCompile for publication-ready reviews; exportMermaid visualizes VWF multimer patterns.
Use Cases
"Analyze VWF mutation frequencies in type 1 VWD Canadian cohort vs European MCMDM-1VWD"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas merge of James 2006 and Goodeve 2006 mutation tables) → statistical output with p-values and matplotlib allele frequency plots.
"Write LaTeX review on VWD type 2 multimer defects with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText (draft section) → latexSyncCitations (add Ruggeri 1980, Sadler 2006) → latexCompile → PDF with multimer figure.
"Find GitHub repos analyzing VWF gene sequences from VWD papers"
Research Agent → paperExtractUrls (Sadler 1998, James 2006) → Code Discovery → paperFindGithubRepo → githubRepoInspect → curated list of VWF mutation analysis scripts.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ VWD genetics papers: searchPapers → citationGraph → DeepScan 7-step analysis with GRADE checkpoints on mutation penetrance. Theorizer generates hypotheses on ABO-VWF interactions from James et al. (2021) and Sadler (1998), outputting mermaid genotype-phenotype models. DeepScan verifies desmopressin response genetics via CoVe on Revel-Vilk et al. (2013).
Frequently Asked Questions
What defines von Willebrand Disease molecular genetics?
It examines VWF gene mutations causing type 1 (low levels), type 2 (dysfunctional), and type 3 (absent) VWF, classified via sequencing and multimer analysis (Sadler, 1998).
What methods identify VWD mutations?
PCR sequencing of all 52 VWF exons, multimer electrophoresis for type 2 subtypes, and functional assays; Canadian cohort sequenced 106 index cases finding 61 mutations (James et al., 2006).
What are key papers?
Sadler (1998; 1355 citations) reviews VWF genetics; Goodeve et al. (2006; 397 citations) details MCMDM-1VWD genotypes; Revel-Vilk et al. (2013; 3514 citations) covers pediatric DDAVP.
What open problems exist?
Incomplete genotype-phenotype correlations in type 1 VWD due to modifiers like ABO; need better detection of rare variants (Tosetto et al., 2006; James et al., 2006).
Research Platelet Disorders and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching von Willebrand Disease Molecular Genetics with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Platelet Disorders and Treatments Research Guide